-
公开(公告)号:ZA7006474B
公开(公告)日:1971-05-27
申请号:ZA7006474
申请日:1970-09-22
Applicant: HOECHST AG
Inventor: SCHORR M , SCHRINNER E , SCHUETZ E
IPC: C07D499/00 , C07D499/60 , C07D
CPC classification number: C07D499/00
-
公开(公告)号:SE8306994D0
公开(公告)日:1983-12-16
申请号:SE8306994
申请日:1983-12-16
Applicant: HOECHST AG
Inventor: DURCKHEIMER W , BORMANN D , EHLERS E , SCHRINNER E , HAYMES R
IPC: A61K31/397 , A61K31/435 , A61K31/505 , A61K31/535 , A61K31/545 , A61K31/546 , A61P31/04 , B25J15/08 , C07D205/08 , C07D277/20 , C07D277/40 , C07D277/42 , C07D277/50 , C07D463/00 , C07D471/04 , C07D487/04 , C07D498/04 , C07D501/20 , C07D501/24 , C07D501/36 , C07D505/00 , C07D519/06 , C07F9/6561
Abstract: Cephem derivatives of the general formula in which the R2O group is in the syn-position, a process for their manufacture and pharmaceutical formulations which are active against bacterial infections and contain these compounds.
-
公开(公告)号:YU87378A
公开(公告)日:1983-01-21
申请号:YU87378
申请日:1978-04-12
Applicant: HOECHST AG
Inventor: DUERCKHEIMER W , EHLERS E , SELIGER H G , SCHRINNER E
IPC: A61K20060101 , A61K31/545 , A61K31/546 , A61K31/675 , A61K31/695 , A61P31/04 , B23K1/18 , B23Q5/033 , C07D20060101 , C07D277/20 , C07D277/40 , C07D501/00 , C07D501/20 , C07D501/24 , C07D501/34 , C07D501/36 , C07D501/46 , C07D501/59 , C07D501/60 , C07D519/06
Abstract: What are disclosed are cephem compounds of the formula in which R1 denotes hydrogen, an optionally substituted alkyl, acyl, arylsulfonyl or alkylsulfonyl group or an amino-protective group which is known from peptide chemistry, R2 denotes hydrogen or an optionally substituted alkyl, alkenyl, alkinyl, cycloalkyl, aralkyl, acyl, aryl, arylsulfonyl, alkylsulfonyl or heterocyclic group, R3 denotes hydrogen, an ester group or a cation, R4 denotes hydrogen, a lower alkoxy group or a group which can be converted to this, X denotes a SO group in the R or S configuration or a SO2 group and A denotes hydrogen, an optionally substituted alkoxy or alkenyloxy group, halogen or a group -CH2Y, in which Y represents hydrogen, halogen or the radical of a nucleophilic compound, and in which the R2O group is in the syn-position, which compounds are valuable chemotherapeutic agents having a very powerful antimicrobial action against Gram-positive and Gram-negative bacteria and an unexpectedly good action against penicillinase-forming Staphilococci.
-
34.
公开(公告)号:NZ186968A
公开(公告)日:1981-04-24
申请号:NZ18696878
申请日:1978-04-13
Applicant: HOECHST AG
Inventor: SELIGER H , DUERCKHEIMER W , SCHRINNER E , EHLERS E
IPC: A61K20060101 , A61K31/545 , A61K31/546 , A61K31/675 , A61K31/695 , A61P31/04 , B23K1/18 , B23Q5/033 , C07D20060101 , C07D277/20 , C07D277/40 , C07D501/00 , C07D501/20 , C07D501/24 , C07D501/34 , C07D501/36 , C07D501/46 , C07D501/59 , C07D501/60 , C07D519/06
Abstract: What are disclosed are cephem compounds of the formula in which R1 denotes hydrogen, an optionally substituted alkyl, acyl, arylsulfonyl or alkylsulfonyl group or an amino-protective group which is known from peptide chemistry, R2 denotes hydrogen or an optionally substituted alkyl, alkenyl, alkinyl, cycloalkyl, aralkyl, acyl, aryl, arylsulfonyl, alkylsulfonyl or heterocyclic group, R3 denotes hydrogen, an ester group or a cation, R4 denotes hydrogen, a lower alkoxy group or a group which can be converted to this, X denotes a SO group in the R or S configuration or a SO2 group and A denotes hydrogen, an optionally substituted alkoxy or alkenyloxy group, halogen or a group -CH2Y, in which Y represents hydrogen, halogen or the radical of a nucleophilic compound, and in which the R2O group is in the syn-position, which compounds are valuable chemotherapeutic agents having a very powerful antimicrobial action against Gram-positive and Gram-negative bacteria and an unexpectedly good action against penicillinase-forming Staphilococci.
-
公开(公告)号:ZA792571B
公开(公告)日:1980-06-25
申请号:ZA792571
申请日:1979-05-25
Applicant: HOECHST AG
Inventor: SCHRINNER E , DUERCHHEIMER W , BORMANN D
IPC: C07D501/22 , A61K31/545 , A61K31/546 , A61P31/04 , C07D277/24 , C07D277/28 , C07D277/32 , C07D501/20 , C07D501/34 , C07D
-
公开(公告)号:ZA787209B
公开(公告)日:1979-12-27
申请号:ZA787209
申请日:1978-12-21
Applicant: HOECHST AG
Inventor: BLUMBACH J , SCHRINNER E , DUEREKHEIMER W
IPC: C07D501/06 , A61K31/545 , A61K31/546 , A61P31/04 , C07D277/20 , C07D277/46 , C07D501/34 , C07D , A61K
Abstract: Cephalosporin derivatives of the formula I processes for their manufacture and their use for combating bacterial infections.
-
公开(公告)号:ZA781433B
公开(公告)日:1979-02-28
申请号:ZA781433
申请日:1978-03-10
Applicant: HOECHST AG
Inventor: SCHRINNER E , BORMANN D , KNABE B , WORM M
IPC: A61K31/44 , A61K31/535 , A61K31/545 , A61K31/546 , A61P31/04 , C07D277/20 , C07D277/38 , C07D277/40 , C07D463/00 , C07D501/20 , C07D505/00 , A61K31/00
Abstract: Cephem derivatives of the formula in which R1 denotes hydrogen or low-molecular alkoxy, R2 denotes hydrogen, optionally substituted alkyl, phthalide or a cation, X denotes sulfur, oxygen or CH2 and A denotes hydrogen, alkoxy, halogen or a group -CH2Y, in which Y represents hydrogen, acyloxy, alkoxy, optionally substituted carbamoyloxy or a group -SR3, in which R3 can represent acyl, alkyl or an optionally substituted 5-membered or 6-membered heterocyclic structure are disclosed as valuable antibiotics which are well suited for combating Gram-positive and in particular Gram-negative infections and also have an unexpectedly good action against penicillinase-forming staphylococci.
-
公开(公告)号:LU79350A1
公开(公告)日:1978-11-27
申请号:LU79350
申请日:1978-03-31
Applicant: HOECHST AG
Inventor: DUERCKHEIMER W , SCHRINNER E , HEYMES R , EHLERS E , BORMANN D
IPC: A61K31/397 , A61K31/435 , A61K31/505 , A61K31/535 , A61K31/545 , A61K31/546 , A61P31/04 , B25J15/08 , C07D205/08 , C07D277/20 , C07D277/40 , C07D277/42 , C07D277/50 , C07D463/00 , C07D471/04 , C07D487/04 , C07D498/04 , C07D501/20 , C07D501/24 , C07D501/36 , C07D505/00 , C07D519/06 , C07F9/6561 , C07D , A61K
-
公开(公告)号:SE7803660L
公开(公告)日:1978-10-03
申请号:SE7803660
申请日:1978-03-31
Applicant: HOECHST AG
Inventor: DURCKHEIMER W , BORMANN D , EHLERS E , SCHRINNER E , HAYMES R
IPC: A61K31/397 , A61K31/435 , A61K31/505 , A61K31/535 , A61K31/545 , A61K31/546 , A61P31/04 , B25J15/08 , C07D205/08 , C07D277/20 , C07D277/40 , C07D277/42 , C07D277/50 , C07D463/00 , C07D471/04 , C07D487/04 , C07D498/04 , C07D501/20 , C07D501/24 , C07D501/36 , C07D505/00 , C07D519/06 , C07F9/6561 , C07D501/34 , C07D487/02
Abstract: Cephem derivatives of the general formula in which the R2O group is in the syn-position, a process for their manufacture and pharmaceutical formulations which are active against bacterial infections and contain these compounds.
-
公开(公告)号:SE7514094L
公开(公告)日:1976-06-14
申请号:SE7514094
申请日:1975-12-12
Applicant: HOECHST AG
Inventor: SCHORR M , SCHRINNER E , SCHMITT W
IPC: C07D499/66 , C07D499/00 , C07D499/64 , C07D499/68 , C07D499/70
Abstract: Acylaminopenicillanic acids of the general formula in which R1, R2 and R3 represent hydrogen or lower alkyl which may be substituted, and in which the radicals R1 and R2 or R2 and R3 may form together an alkylene radical which may be substituted, R4 and R5 represent hydrogen or lower alkyl, R6 represents phenyl which may be substituted, a monocyclic aromatic heterocycle which may be substituted, or dihydrophenyl, A represents a benzene or thiophene ring which may be substituted, and X represents oxygen or a single bond, a process for preparing them and pharmaceutical compositions active against bacterial infections containing these compounds.
-
-
-
-
-
-
-
-
-